| Financial Year |
March 31 2023 |
| Monetary Funds |
302,860,342.80 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
14,107,630.56 |
| Accounts Receivable |
782,872,144.91 |
| Advances to Suppliers |
50,402,236.91 |
| Other Receivables |
14,403,271.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
931,888,228.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
136,495,875.28 |
| Total Current Assets |
2,300,811,490.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
10,746,263.51 |
| Fixed Assetes |
1,580,290,390.98 |
| Under-construction Projects |
41,293,926.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
163,151,305.90 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,850,577.40 |
| Deferred Income Tax Assets |
82,227,680.94 |
| Other Non-Current Assets |
98,769,908.58 |
| Sub-Total of Non-Current Assets |
1,981,330,054.09 |
| Total Assets |
4,282,141,544.12 |
| Short-Term Loans |
548,380,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
705,184,890.00 |
| Accounts Payable |
548,916,950.45 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
45,367,540.33 |
| Taxes Payable |
13,925,789.82 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
19,594,369.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,000,000.00 |
| Other Current Liabilities |
392,820.10 |
| Sub-Total of Current Liabilities |
1,899,784,052.99 |
| Long-term Loans |
7,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
927,744.92 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,976,521.25 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
20,509,529.53 |
| Total Liabilities |
1,920,293,582.52 |
| Paid-In Capital(Or Share Stock) |
500,711,814.00 |
| Capital Surplus |
932,307,866.13 |
| Surplus Reserve |
105,822,732.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
828,887,857.26 |
| Minority Stockholder's Interest |
-5,882,308.35 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,367,730,269.95 |
| Owner's Equity（Stockholder's Equity） |
2,361,847,961.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,282,141,544.12 |
